Our results showed that the expression levels of p-PERK, p-elf2, and ATF-4 were all enhanced after IH treatment; however, the expression levels of p-IRE1 and active ATF-6 were not elevated, suggesting that the IRE1 and ATF6 pathways are probably not involved in this process. The gene discussed is ATF6; the disease is isolated hemihyperplasia.